# Carle Health Care Inc Reproductive Reproductive Windsor – FDA Inspection, Aug 15, 2018

Source: https://www.keypedia.com/records/fda_inspections/carle-health-care-inc-reproductive-reproductive-windsor/fbc9e88c-068d-48ee-8742-d7e0398b4248
Source feed: FDA_Inspections

> FDA inspection 1063414 of Carle Health Care Inc Reproductive Reproductive Windsor, August 15, 2018. Classification: Voluntary Action Indicated (VAI). 1 citation under 21 CFR part 1271. Form 483 issued. 4 other FDA inspections on record for this company.

---

## Details

- Record Type: FDA Inspection
- Inspection ID: 1063414
- Company Name: Carle Health Care Inc Reproductive Reproductive Windsor
- Inspection Date: 2018-08-15
- Classification: Voluntary Action Indicated (VAI)
- Classification Code: VAI
- Project Area: Human Cellular, Tissue, and Gene Therapies
- Product Type: Biologics
- Center: Biologics
- Office Name: Center for Biologics Evaluation and Research
- Citation Count: 1

## Related Documents

- FDA Inspection 1335568 - 2026-08-24
- FDA Inspection 1190733 - 2022-11-08
- FDA Inspection 968472 - 2016-04-11
- FDA Inspection 883128 - 2014-06-13

## Related Officers

- [Company Rep](https://www.keypedia.com/people/neali-h-lucas/2f08b1c2-8a68-4785-a587-0112e54f6774)
- [Issuing Officer](https://www.keypedia.com/people/uruaku-a-obasi/8ff0e6f4-da89-4ec0-86f4-7ebf8cf529b8)

Company: https://www.keypedia.com/companies/carle-health-care-inc-reproductive-reproductive-windsor/e9bb0264-d0f2-4a7f-ba94-98debc058579

Office: https://www.keypedia.com/offices/center-for-biologics-evaluation-and-research/dd9e8ea7-6f04-4ed1-b0d7-e7e6b264570d